SCHEMBL5029959

SCHEMBL5029959

CCOC(=O)c1ccc2[nH]nc(/C=C/c3ccc4occc4c3)c2c1OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.36
AURKA O14965 1/20 0.35
CTNNB1 P35222 1/20 0.34
WNT3A P56704 1/20 0.34
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 4/20 0.34
HPGD P15428 4/20 0.34
CA12 O43570 1/20 0.34
CA2 P00918 1/20 0.34
GLA P06280 1/20 0.34
CA3 P07451 1/20 0.34
GAA P10253 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5029964 1.00 MAOB (0.36) MAOBAURKACTNNB1WNT3AKDM4E
SCHEMBL5032496 0.88 KCNA3 (0.36) CTNNB1WNT3AKDM4ENPC1RAB9A
SCHEMBL5032493 0.88 KCNA3 (0.36) CTNNB1WNT3AKDM4ENPC1RAB9A
SCHEMBL4149953 0.83 CHEK1 (0.46) KDM4EALDH1A1HPGDLMNAHTT
SCHEMBL4149958 0.83 CHEK1 (0.46) KDM4EALDH1A1HPGDLMNAHTT
SCHEMBL5034299 0.83 AURKA (0.33) AURKACTNNB1WNT3AKDM4EALDH1A1
SCHEMBL5034297 0.83 AURKA (0.33) AURKACTNNB1WNT3AKDM4EALDH1A1
SCHEMBL4136172 0.83 NPC1 (0.38) AURKAKDM4EALDH1A1HPGDNPC1
SCHEMBL4136174 0.83 NPC1 (0.38) AURKAKDM4EALDH1A1HPGDNPC1
SCHEMBL5029987 0.82 ACSS2 (0.36) AURKACTNNB1WNT3AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429609-B2 Pyrazole compound and medicinal composition containing the same EISAI R & D MANAGEMENT CO., LTD. (JP) 2008-09-30 US disclosed
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed
EP-1510516-A1 PYRAZOLE COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME Eisai Co., Ltd. (JP) 2005-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same CNKSR1, NR3C2, CSNK2B MAOB 2177/4885AURKA 710/4885CTNNB1 435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.